13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001447228
Total reported value
$291.3M
$291.3M
22 檔
510.1%
During the Q1 2024 filing period, Yiheng Capital Management, L.P. (CIK: 0001447228) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $291.3M across 22 reported positions.
In Q1 2024, Yiheng Capital Management, L.P. adopted a defensive or profit-taking posture, trimming 11 positions and completely liquidating 2 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including SMCIUSD, JD, BILI) accounted for 510.1% of total reported equity market value during Q1 2024.
Top New Position Initiated
SMCIUSD
市值: $567.3M
Top Position Liquidated / Trimmed
BIRD
前期市值: $1.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SMCIUSD | Super Micro Computer Inc | Stock-Other | 31.44% | — | — | |
| 2 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 26.97% | +5.02% | -14.90% | |
| 3 | BILI | Bilibili Inc-sponsored Adr | Stock-Other | 15.45% | +5.11% | -9.54% | |
| 4 | NOAH | Noah Holdings Ltd-spon Ads | Stock-Other | 4.26% | -5.79% | — | |
| 5 | HTHT | H World Group Ltd-adr | Stock-Other | 4.24% | -2.42% | -29.03% | |
| 6 | EDU | New Oriental Educatio-sp Adr | Stock-Consumer Staples | 3.40% | +1.79% | -44.68% | |
| 7 | RBLX | Roblox CORP -class A | Stock-Comm Services | 3.28% | — | -74.03% | |
| 8 | TDG | Transdigm Group Inc | Stock-Industrials | 2.12% | — | -39.79% | |
| 9 | AKRO | Akero Therapeutics Inc | Stock-Other | 2.01% | — | -25.45% | |
| 10 | BEAM | Beam Therapeutics Inc | Stock-Other | 1.55% | +0.03% | — | |
| 11 | DNLI | Denali Therapeutics Inc | Stock-Other | 1.31% | — | — | |
| 12 | TAL | Tal Education Group- Adr | Stock-Consumer Staples | 1.22% | -1.25% | -0.13% | |
| 13 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.92% | +0.76% | -22.82% | |
| 14 | ACMR | Acm Research Inc-class A | Stock-Other | 0.78% | — | -6.13% | |
| 15 | IVA | Inventiva SA - Adr | Stock-Other | 0.53% | — | — | |
| 16 | ✓ | Stock-Other | 0.23% | — | +6.25% | ||
| 17 | JOYY | Joyy Inc-adr | Stock-Other | 0.16% | -0.23% | — | |
| 18 | VISN | Vistance Networks Inc | Stock-Tech | 0.05% | — | — | |
| 19 | GBIOGBX | Generation Bio Co | Stock-Other | 0.04% | — | — | |
| 20 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.02% | — | -97.70% | |
| 21 | RERE | Atrenew Inc | Stock-Other | 0.02% | -2.23% | — | |
| 22 | ✓ | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SMCIUSD | Super Micro Computer Inc | +31.4% | NEW | New buy |
| 2 | BEAM | Beam Therapeutics Inc | +0.2% | — | Unchanged |
| 3 | ACMR | Acm Research Inc-class A | +0.2% | -6.13% | Trim |
| 4 | JOYY | Joyy Inc-adr | +0.2% | NEW | New buy |
| 5 | GBIOGBX | Generation Bio Co | 0% | NEW | New buy |
| 6 | RERE | Atrenew Inc | — | — | Unchanged |
| 7 | AIJTY | Jianpu Technology Inc-sp Adr | — | EXIT | Sold out |
| 8 | ✓ | — | NEW | New buy | |
| 9 | ✓ | -0.1% | +6.25% | Add | |
| 10 | VISN | Vistance Networks Inc | -0.1% | — | Unchanged |
| 11 | BIRD | Smartbird, Inc | -0.1% | EXIT | Sold out |
| 12 | DNLI | Denali Therapeutics Inc | -0.1% | — | Unchanged |
| 13 | IVA | Inventiva SA - Adr | -0.2% | — | Unchanged |
| 14 | TAL | Tal Education Group- Adr | -0.2% | -0.13% | Trim |
| 15 | AKRO | Akero Therapeutics Inc | -0.6% | -25.45% | Trim |
| 16 | VRDN | Viridian Therapeutics Inc | -0.6% | -22.82% | Trim |
| 17 | TDG | Transdigm Group Inc | -0.9% | -39.79% | Trim |
| 18 | CRSP | CRISPR Therapeutics AG | -1% | -97.70% | Trim |
| 19 | NOAH | Noah Holdings Ltd-spon Ads | -1.1% | — | Unchanged |
| 20 | HTHT | H World Group Ltd-adr | -1.1% | -29.03% | Trim |
| 21 | EDU | New Oriental Educatio-sp Adr | -2% | -44.68% | Trim |
| 22 | BILI | Bilibili Inc-sponsored Adr | -3.9% | -9.54% | Trim |
| 23 | JD | Jd.com Inc-adr | -7.8% | -14.90% | Trim |
| 24 | RBLX | Roblox CORP -class A | -12.5% | -74.03% | Trim |
According to official SEC Form 13F filings, Yiheng Capital Management, L.P. reported a total U.S. public equity portfolio value of $291.3M across 22 disclosed positions in Q1 2024.
During Q1 2024, Yiheng Capital Management, L.P.'s top holdings by market value included SMCIUSD (31.4%)、JD (27.0%)、BILI (15.4%). The largest single position, SMCIUSD, represented 31.4% of total portfolio value.
In Q1 2024, Yiheng Capital Management, L.P. made 18 total portfolio adjustments, initiating 4 new buys, adding to 1 positions, trimming 11 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.